YDES YD Bio Limited
$5.42▲ +2.46%
Healthcare
Other
Volume 7.5K
Avg Volume (10D) 103.0K
Key Metrics & Fundamentals
Market Cap
$383.91M
P/E Ratio
739.9
Div Yield
0.00%
52W Range
1.70 - 17.37
% vs 50 MA
6.38%
% vs 200 MA
-6.23%
RSI-14
48.1
MACD Histogram
-0.2700
Beta (1Y vs SPY)
0.17
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
YD Bio and EG BioMed Partner with JoiiUp to Launch AI-Driven Cancer Risk Assessment for Corporate Wellness Programs
GlobeNewswire · Oct 20, 2026 8:00 AM ET
YD Bio and EG BioMed Launch AI-Based 10-Cancer Risk Factor Assessment
GlobeNewswire · Oct 6, 2026 8:00 AM ET
YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
GlobeNewswire · Aug 11, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.